Biotech News

SI-BONE To Report Fourth-Quarter and Full-Year 2025 Financial Results on February 23, 2026

Si-Bone (SIBN)Si-Bone2026-06-25 13:46 ESTEarnings

SANTA CLARA, Calif., Feb. 02, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone, today announced it will report financial results for the fourth quarter and full year ended

Open original release

Related news

SIBNSi-Bone2026-06-25 13:46 EST

SI-BONE To Present at Truist Securities 2026 MedTech Conference on June 16, 2026

SIBNSi-Bone2026-06-25 13:46 EST

SI-BONE, Inc. Reports Financial Results for the First Quarter 2026 and Raises 2026 Guidance

SIBNSi-Bone2026-06-25 13:46 EST

SI-BONE to Present at Morgan Stanley 23rd Global Healthcare Conference on September 9, 2025

SIBNSi-Bone2026-06-25 13:46 EST

SI-BONE To Report Third Quarter 2025 Financial Results on November 10, 2025

SIBNSi-Bone2026-06-25 13:46 EST

SI-BONE, Inc. Reports Financial Results for the Third Quarter 2025 and Raises 2025 Guidance

SIBNSi-Bone2026-06-25 13:46 EST

SI-BONE To Present at Piper Sandler 37th Annual Healthcare Conference on December 2, 2025

SIBNSi-Bone2026-06-25 13:46 EST

SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2025

SIBNSi-Bone2026-06-25 13:46 EST

SI-BONE To Present at TD Cowen 46th Annual Health Care Conference on March 2, 2026

SIBNSi-Bone2026-06-25 13:46 EST

SI-BONE, Inc. Reports Record Financial Results for the Fourth Quarter 2025 and Issues 2026 Guidance

SIBNSi-Bone2026-06-25 13:46 EST

SI-BONE To Present at BofA Securities 2026 Healthcare Conference on May 12, 2026

View all latest news

Si-Bone

Si-Bone is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

Recent company news

SIBNSi-Bone2026-06-26 13:23 EST

SI-BONE To Present at Truist Securities 2026 MedTech Conference on June 16, 2026

SIBNSi-Bone2026-06-26 13:23 EST

SI-BONE, Inc. Reports Financial Results for the First Quarter 2026 and Raises 2026 Guidance

SIBNSi-Bone2026-06-26 13:23 EST

SI-BONE to Present at Morgan Stanley 23rd Global Healthcare Conference on September 9, 2025

SIBNSi-Bone2026-06-26 13:23 EST

SI-BONE To Report Third Quarter 2025 Financial Results on November 10, 2025

SIBNSi-Bone2026-06-26 13:23 EST

SI-BONE, Inc. Reports Financial Results for the Third Quarter 2025 and Raises 2025 Guidance

Stock data

Close: —
Market cap: —
Exchange: NASDAQ
Sector: Biotechnology
Location: United States